China Antimicrobial Peptides Market Report & Forecast 2021-2027

1 Introduction to Research & Analysis Reports
1.1 Antimicrobial Peptides Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Antimicrobial Peptides Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 China Antimicrobial Peptides Overall Market Size
2.1 China Antimicrobial Peptides Market Size: 2021 VS 2027
2.2 China Antimicrobial Peptides Revenue, Prospects & Forecasts: 2016-2027
2.3 China Antimicrobial Peptides Sales: 2016-2027

3 Company Landscape
3.1 Top Antimicrobial Peptides Players in China Market
3.2 Top China Antimicrobial Peptides Companies Ranked by Revenue
3.3 China Antimicrobial Peptides Revenue by Companies
3.4 China Antimicrobial Peptides Sales by Companies
3.5 China Antimicrobial Peptides Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Antimicrobial Peptides Companies in China Market, by Revenue in 2020
3.7 Manufacturers Antimicrobial Peptides Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antimicrobial Peptides Players in China Market
3.8.1 List of Tier 1 Antimicrobial Peptides Companies in China
3.8.2 List of Tier 2 and Tier 3 Antimicrobial Peptides Companies in China

4 Sights by Type
4.1 Overview
4.1.1 By Type - China Antimicrobial Peptides Market Size Markets, 2021 & 2027
4.1.2 Plant Antimicrobial Peptides
4.1.3 Microbial Antimicrobial Peptides
4.1.4 Animal Antimicrobial Peptides
4.2 By Type - China Antimicrobial Peptides Revenue & Forecasts
4.2.1 By Type - China Antimicrobial Peptides Revenue, 2016-2021
4.2.2 By Type - China Antimicrobial Peptides Revenue, 2022-2027
4.2.3 By Type - China Antimicrobial Peptides Revenue Market Share, 2016-2027
4.3 By Type - China Antimicrobial Peptides Sales & Forecasts
4.3.1 By Type - China Antimicrobial Peptides Sales, 2016-2021
4.3.2 By Type - China Antimicrobial Peptides Sales, 2022-2027
4.3.3 By Type - China Antimicrobial Peptides Sales Market Share, 2016-2027
4.4 By Type - China Antimicrobial Peptides Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - China Antimicrobial Peptides Market Size, 2021 & 2027
5.1.2 Pharmaceuticals
5.1.3 Feed Additives
5.1.4 Others
5.2 By Application - China Antimicrobial Peptides Revenue & Forecasts
5.2.1 By Application - China Antimicrobial Peptides Revenue, 2016-2021
5.2.2 By Application - China Antimicrobial Peptides Revenue, 2022-2027
5.2.3 By Application - China Antimicrobial Peptides Revenue Market Share, 2016-2027
5.3 By Application - China Antimicrobial Peptides Sales & Forecasts
5.3.1 By Application - China Antimicrobial Peptides Sales, 2016-2021
5.3.2 By Application - China Antimicrobial Peptides Sales, 2022-2027
5.3.3 By Application - China Antimicrobial Peptides Sales Market Share, 2016-2027
5.4 By Application - China Antimicrobial Peptides Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 AnaSpec
6.1.1 AnaSpec Corporation Information
6.1.2 AnaSpec Overview
6.1.3 AnaSpec Antimicrobial Peptides Sales and Revenue in China Market (2016-2021)
6.1.4 AnaSpec Antimicrobial Peptides Product Description
6.1.5 AnaSpec Recent Developments
6.2 AMP Biotech
6.2.1 AMP Biotech Corporation Information
6.2.2 AMP Biotech Overview
6.2.3 AMP Biotech Antimicrobial Peptides Sales and Revenue in China Market (2016-2021)
6.2.4 AMP Biotech Antimicrobial Peptides Product Description
6.2.5 AMP Biotech Recent Developments
6.3 Phoenix Biotech
6.3.1 Phoenix Biotech Corporation Information
6.3.2 Phoenix Biotech Overview
6.3.3 Phoenix Biotech Antimicrobial Peptides Sales and Revenue in China Market (2016-2021)
6.3.4 Phoenix Biotech Antimicrobial Peptides Product Description
6.3.5 Phoenix Biotech Recent Developments
6.4 Novabiotics
6.4.1 Novabiotics Corporation Information
6.4.2 Novabiotics Overview
6.4.3 Novabiotics Antimicrobial Peptides Sales and Revenue in China Market (2016-2021)
6.4.4 Novabiotics Antimicrobial Peptides Product Description
6.4.5 Novabiotics Recent Developments
6.5 Chinese Peptide
6.5.1 Chinese Peptide Corporation Information
6.5.2 Chinese Peptide Overview
6.5.3 Chinese Peptide Antimicrobial Peptides Sales and Revenue in China Market (2016-2021)
6.5.4 Chinese Peptide Antimicrobial Peptides Product Description
6.5.5 Chinese Peptide Recent Developments
6.6 Ontores
6.6.1 Ontores Corporation Information
6.6.2 Ontores Overview
6.6.3 Ontores Antimicrobial Peptides Sales and Revenue in China Market (2016-2021)
6.6.4 Ontores Antimicrobial Peptides Product Description
6.6.5 Ontores Recent Developments
6.7 GenScript
6.7.1 GenScript Corporation Information
6.7.2 GenScript Overview
6.7.3 GenScript Antimicrobial Peptides Sales and Revenue in China Market (2016-2021)
6.7.4 GenScript Antimicrobial Peptides Product Description
6.7.5 GenScript Recent Developments
6.8 Hycult Biotech
6.8.1 Hycult Biotech Corporation Information
6.8.2 Hycult Biotech Overview
6.8.3 Hycult Biotech Antimicrobial Peptides Sales and Revenue in China Market (2016-2021)
6.8.4 Hycult Biotech Antimicrobial Peptides Product Description
6.8.5 Hycult Biotech Recent Developments
6.9 Sunsmile
6.9.1 Sunsmile Corporation Information
6.9.2 Sunsmile Overview
6.9.3 Sunsmile Antimicrobial Peptides Sales and Revenue in China Market (2016-2021)
6.9.4 Sunsmile Antimicrobial Peptides Product Description
6.9.5 Sunsmile Recent Developments
6.10 Ruixing Biotechnology
6.10.1 Ruixing Biotechnology Corporation Information
6.10.2 Ruixing Biotechnology Overview
6.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales and Revenue in China Market (2016-2021)
6.10.4 Ruixing Biotechnology Antimicrobial Peptides Product Description
6.10.5 Ruixing Biotechnology Recent Developments
6.11 Zhongnong Yingtai Biotechnology
6.11.1 Zhongnong Yingtai Biotechnology Corporation Information
6.11.2 Zhongnong Yingtai Biotechnology Overview
6.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales and Revenue in China Market (2016-2021)
6.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Description
6.11.5 Zhongnong Yingtai Biotechnology Recent Developments
6.12 Glam Technology
6.12.1 Glam Technology Corporation Information
6.12.2 Glam Technology Overview
6.12.3 Glam Technology Antimicrobial Peptides Sales and Revenue in China Market (2016-2021)
6.12.4 Glam Technology Antimicrobial Peptides Product Description
6.12.5 Glam Technology Recent Developments
6.13 ProteLight Pharmaceutical & Biotechnology
6.13.1 ProteLight Pharmaceutical & Biotechnology Corporation Information
6.13.2 ProteLight Pharmaceutical & Biotechnology Overview
6.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales and Revenue in China Market (2016-2021)
6.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Description
6.13.5 ProteLight Pharmaceutical & Biotechnology Recent Developments

7 China Antimicrobial Peptides Production Capacity, Analysis
7.1 China Antimicrobial Peptides Production Capacity, 2016-2027
7.2 Antimicrobial Peptides Production Capacity of Key Manufacturers in China Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 Antimicrobial Peptides Supply Chain Analysis
9.1 Antimicrobial Peptides Industry Value Chain
9.2 Antimicrobial Peptides Upstream Market
9.3 Antimicrobial Peptides Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Antimicrobial Peptides Distributors and Sales Agents in China Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer

List of Tables
Table 1. Key Players of Antimicrobial Peptides in China Market
Table 2. Top Antimicrobial Peptides Players in China Market, Ranking by Revenue (2019)
Table 3. China Antimicrobial Peptides Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Antimicrobial Peptides Revenue Share by Companies, 2016-2021
Table 5. China Antimicrobial Peptides Sales by Companies, (Mg), 2016-2021
Table 6. China Antimicrobial Peptides Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Antimicrobial Peptides Price (2016-2021) & (US$/Mg)
Table 8. Manufacturers Antimicrobial Peptides Product Type
Table 9. List of Tier 1 Antimicrobial Peptides Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Antimicrobial Peptides Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Plant Antimicrobial Peptides
Table 12. Major Manufacturers of Microbial Antimicrobial Peptides
Table 13. By Type Ð China Antimicrobial Peptides Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Antimicrobial Peptides Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Antimicrobial Peptides Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Antimicrobial Peptides Sales (Mg), 2016-2021
Table 17. By Type - China Antimicrobial Peptides Sales (Mg), 2022-2027
Table 18. By Application Ð China Antimicrobial Peptides Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Antimicrobial Peptides Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Antimicrobial Peptides Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Antimicrobial Peptides Sales (Mg), 2016-2021
Table 22. By Application - China Antimicrobial Peptides Sales (Mg), 2022-2027
Table 23. AnaSpec Corporation Information
Table 24. AnaSpec Description and Major Businesses
Table 25. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Gross Margin (US$/Mg) (2016-2021)
Table 26. AnaSpec Antimicrobial Peptides Product
Table 27. AnaSpec Recent Developments
Table 28. AMP Biotech Corporation Information
Table 29. AMP Biotech Description and Major Businesses
Table 30. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Gross Margin (US$/Mg) (2016-2021)
Table 31. AMP Biotech Antimicrobial Peptides Product
Table 32. AMP Biotech Recent Developments
Table 33. Phoenix Biotech Corporation Information
Table 34. Phoenix Biotech Description and Major Businesses
Table 35. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Gross Margin (US$/Mg) (2016-2021)
Table 36. Phoenix Biotech Antimicrobial Peptides Product
Table 37. Phoenix Biotech Recent Developments
Table 38. Novabiotics Corporation Information
Table 39. Novabiotics Description and Major Businesses
Table 40. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Gross Margin (US$/Mg) (2016-2021)
Table 41. Novabiotics Antimicrobial Peptides Product
Table 42. Novabiotics Recent Developments
Table 43. Chinese Peptide Corporation Information
Table 44. Chinese Peptide Description and Major Businesses
Table 45. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Gross Margin (US$/Mg) (2016-2021)
Table 46. Chinese Peptide Antimicrobial Peptides Product
Table 47. Chinese Peptide Recent Developments
Table 48. Ontores Corporation Information
Table 49. Ontores Description and Major Businesses
Table 50. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Gross Margin (US$/Mg) (2016-2021)
Table 51. Ontores Antimicrobial Peptides Product
Table 52. Ontores Recent Developments
Table 53. GenScript Corporation Information
Table 54. GenScript Description and Major Businesses
Table 55. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Gross Margin (US$/Mg) (2016-2021)
Table 56. GenScript Antimicrobial Peptides Product
Table 57. GenScript Recent Developments
Table 58. Hycult Biotech Corporation Information
Table 59. Hycult Biotech Description and Major Businesses
Table 60. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Gross Margin (US$/Mg) (2016-2021)
Table 61. Hycult Biotech Antimicrobial Peptides Product
Table 62. Hycult Biotech Recent Developments
Table 63. Sunsmile Corporation Information
Table 64. Sunsmile Description and Major Businesses
Table 65. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Gross Margin (US$/Mg) (2016-2021)
Table 66. Sunsmile Antimicrobial Peptides Product
Table 67. Sunsmile Recent Developments
Table 68. Ruixing Biotechnology Corporation Information
Table 69. Ruixing Biotechnology Description and Major Businesses
Table 70. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Gross Margin (US$/Mg) (2016-2021)
Table 71. Ruixing Biotechnology Antimicrobial Peptides Product
Table 72. Ruixing Biotechnology Recent Developments
Table 73. Zhongnong Yingtai Biotechnology Corporation Information
Table 74. Zhongnong Yingtai Biotechnology Description and Major Businesses
Table 75. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Gross Margin (US$/Mg) (2016-2021)
Table 76. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product
Table 77. Zhongnong Yingtai Biotechnology Recent Developments
Table 78. Glam Technology Corporation Information
Table 79. Glam Technology Description and Major Businesses
Table 80. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Gross Margin (US$/Mg) (2016-2021)
Table 81. Glam Technology Antimicrobial Peptides Product
Table 82. Glam Technology Recent Developments
Table 83. ProteLight Pharmaceutical & Biotechnology Corporation Information
Table 84. ProteLight Pharmaceutical & Biotechnology Description and Major Businesses
Table 85. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$, Mn) and Gross Margin (US$/Mg) (2016-2021)
Table 86. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product
Table 87. ProteLight Pharmaceutical & Biotechnology Recent Developments
Table 88. Antimicrobial Peptides Production Capacity (Mg) of Key Manufacturers in China Market, 2019-2021 (Mg)
Table 89. China Antimicrobial Peptides Capacity Market Share of Key Manufacturers, 2019-2021
Table 90. Antimicrobial Peptides Market Opportunities & Trends in China Market
Table 91. Antimicrobial Peptides Market Drivers in China Market
Table 92. Antimicrobial Peptides Market Restraints in China Market
Table 93. Antimicrobial Peptides Raw Materials
Table 94. Antimicrobial Peptides Raw Materials Suppliers in China Market
Table 95. Typical Antimicrobial Peptides Downstream
Table 96. Antimicrobial Peptides Downstream Clients in China Market
Table 97. Antimicrobial Peptides Distributors and Sales Agents in China Market
List of Figures
Figure 1. Antimicrobial Peptides Product Picture
Figure 2. Antimicrobial Peptides Segment by Type
Figure 3. Antimicrobial Peptides Segment by Application
Figure 4. China Antimicrobial Peptides Market Overview: 2020
Figure 5. China Antimicrobial Peptides Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Antimicrobial Peptides Revenue, 2016-2027 (US$, Mn)
Figure 7. Antimicrobial Peptides Sales in China Market: 2016-2027 (Mg)
Figure 8. The Top 3 and 5 Players Market Share by Antimicrobial Peptides Revenue in 2020
Figure 9. Plant Antimicrobial Peptides Product Picture
Figure 10. Microbial Antimicrobial Peptides Product Picture
Figure 11. Animal Antimicrobial Peptides Product Picture
Figure 12. By Type - China Antimicrobial Peptides Sales Market Share, 2016-2027
Figure 13. By Type - China Antimicrobial Peptides Revenue Market Share, 2016-2027
Figure 14. By Type - China Antimicrobial Peptides Price (US$/Mg), 2016-2027
Figure 15. Pharmaceuticals
Figure 16. Feed Additives
Figure 17. Others
Figure 18. By Application - China Antimicrobial Peptides Sales Market Share, 2016-2027
Figure 19. By Application - China Antimicrobial Peptides Revenue Market Share, 2016-2027
Figure 20. By Application - China Antimicrobial Peptides Price (US$/Mg), 2016-2027
Figure 21. AnaSpec Antimicrobial Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. AMP Biotech Antimicrobial Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Phoenix Biotech Antimicrobial Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Novabiotics Antimicrobial Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Chinese Peptide Antimicrobial Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Ontores Antimicrobial Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. GenScript Antimicrobial Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Hycult Biotech Antimicrobial Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Sunsmile Antimicrobial Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Ruixing Biotechnology Antimicrobial Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Glam Technology Antimicrobial Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. China Antimicrobial Peptides Production Capacity (Mg), 2016-2027
Figure 35. Antimicrobial Peptides Industry Value Chain
Figure 36. Marketing Channels

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.